was going to approve the Pfizer vaccine in any case, some experts warned that the pressure from the White House could undermine public trust in the agency’s decision-making. A similar vaccine, developed by Moderna, is also under review by the F.D.A. On Friday, the federal government announced it had ordered another 100 million doses from Moderna, adding to a deal this summer for an initial supply of 100 million doses. Other vaccines, including ones developed by Johnson & Johnson and AstraZeneca, are in late-stage trials and could be authorized in the next few months. Dr. Samu Queen, a physician in Portland, Ore., said her geriatric patients are especially eager to receive the vaccine.

Source: New York Times December 12, 2020 02:11 UTC